Pediatric Teduglutide Registry

NCT04832087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2023-12-11

No results posted yet for this study

Summary

Pediatric specific post-marketing registry to evaluate the long-term safety and efficacy of teduglutide.

Conditions

  • Short Bowel Syndrome

Interventions

DRUG

Teduglutide

Standard of care Teduglutide dosing

Sponsors & Collaborators

Principal Investigators

  • Lissette Jimenez · Boston Children's Hospital

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-18
Primary Completion
2023-08-31
Completion
2023-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04832087 on ClinicalTrials.gov